Expert highlights research innovation and is optimistic about the future of IBS treatment
UEG Week presents new research on current therapies for irritable bowel syndrome
2014-10-21
(Press-News.org) (Vienna, October 21, 2014) Patients with irritable bowel syndrome (IBS) may at last be able to hope for a brighter future as innovative new treatments emerge and researchers clarify the role of current therapies. Dr Alexander C. Ford from the Leeds Gastroenterology Institute in Leeds, UK, tells journalists attending the 22nd United European Gastroenterology Week (UEG Week 2014) in Vienna, Austria, that significant progress was being made in drug development for IBS, thanks to the intense research efforts of scientists around the world. "Researchers have dedicated many years to the task of unravelling the pathophysiology of IBS, and it's thanks to these efforts that novel molecular therapies are now in development," he says.
Current Therapies for IBS
IBS is a chronic, relapsing–remitting functional disorder of the gastrointestinal tract, estimated to affect between 5% and 20% of the general population. The symptoms of IBS include recurrent abdominal pain or discomfort and changes in bowel habit, including diarrhoea and/or constipation. Treatment is typically targeted towards the predominant symptoms, with increased intake of soluble fibre and antispasmodic agents frequently used as first-line therapies. Other treatment options with proven efficacy in IBS include certain antidepressants, psychological therapies such as cognitive behavioural therapy and hypnotherapy, and some probiotics. "We currently have a number of fairly effective short-term treatments available for patients with IBS, but, unfortunately, no drug treatment has so far been shown to alter the clinical course of IBS, and the long-term efficacy of current therapies is still unknown," says Dr Ford.
Emerging Drug Therapies
Several promising new types of drug therapy have emerged in recent years for the treatment of IBS. Pro-secretory agents have been found to be effective in constipation-predominant IBS although their precise roles in the IBS treatment algorithm is not yet determined. Bile acid modulators are currently under investigation in IBS patients, with initial studies suggesting efficacy in constipation-predominant IBS.
"The number of novel agents in clinical development for the treatment of IBS is a clear reflection of our growing understanding of the pathogenesis of the condition, but it also demonstrates the extent of the unmet medical need," he says. "I think with the intensity of the research effort going into new IBS treatments, we can be optimistic for both IBS sufferers and the physicians who treat them."
INFORMATION:
References
Ford AC, et al. Am J Gastroenterol 2014;109(Suppl 1):S2–S26.
About UEG Week
UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning.
From October 18-22, 2014, UEG will connect everyone to its annual meeting via livestream on http://www.ueg.eu. State-of-the-art lectures of Europe's largest GI meeting may be followed online from around the world. Include #UEGWeek in your tweets. UEG Week 24/7 features all recorded sessions from UEG Week and provides convenient and direct access to the complete congress material, including E-posters and abstracts.
About UEG
UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.
To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives besides UEG Week, including:
UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion
Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations
UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology
EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe
Find out more about UEG's work. Visit http://www.ueg.eu
Follow UEG on Twitter @my_ueg and @UEGMedia
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2014-10-21
A new study shows that survival and neurological outcomes for patients in cardiac arrest can be improved by adding extracorporeal membrane oxygenation (ECMO) when performing cardiopulmonary resuscitation (CPR). The study abstract was released today in an online supplement of the journal CHEST and will be presented at CHEST 2014, the annual meeting of the American College of Chest Physicians in Austin, Texas held October 25-30.
Despite advances in medical care, less than 20% of people who experience a cardiac arrest make a full recovery. An alternate approach to traditional ...
2014-10-21
PROVIDENCE, R.I. [Brown University] — Scientists think of CD8 T cells as long-lived cells that become tuned to fight just one pathogen, but a new study finds that once CD8 T cells fight one pathogen, they also join the body's "innate" immune system, ready to answer the calls of the cytokine signals that are set off by a wide variety of infections.
Think of CD8 T cells as soldiers who are drafted and trained for a specific mission, but who stay in service, fighting a variety of enemies throughout a long career.
CD8 T cells therefore have more utility than researchers ...
2014-10-21
Eliminating subsidies that help low- and moderate-income people purchase coverage through government-run health insurance marketplaces would sharply boost costs for consumers and cause more than 11 million Americans to lose their health insurance, according to a new RAND Corporation study.
Modeling the likely effects of ending subsidies offered to individuals under the federal Affordable Care Act, researchers found that such a move would increase premium costs in the individual marketplaces by as much as 43 percent and cause enrollment to drop by 68 percent.
"If subsidies ...
2014-10-21
Two Michigan high school students, sisters Ilina and Medha Krishen, have developed screening tools using electronic stethoscopes to detect lung and heart disease. The sisters will present their findings at CHEST 2014 in Austin, Texas next week.
Ilina Krishen became aware of the dangers of smoking and chemical air pollution when she saw the effects of lung disease on family members. Curious to find a way to detect early lung damage in people exposed to noxious air pollutants, Ilina, a high school senior at Port Huron Northern High School in Michigan, developed a screening ...
2014-10-21
Adults typically believe that life gets better — today is better than yesterday was and tomorrow will be even better than today. A new study shows that even depressed individuals believe in a brighter future, but this optimistic belief may not lead to better outcomes. The findings are published in Clinical Psychological Science, a journal of the Association for Psychological Science.
The research shows that middle-aged adults who had a history of depression tended to evaluate their past and current lives in more negative terms than did adults without depression, ...
2014-10-21
TORONTO, Oct. 21, 2014--Controlling the Ebola virus outbreak at the source in West Africa is the most effective way to decrease international risk of transmission, according to a research paper published today in The Lancet.
If the epidemic persists and grows, it's likely there will be more cases of the deadly virus exported to other countries, including Canada, via air travel, said Dr. Kamran Khan, a physician and researcher at St. Michael's Hospital.
Dr. Khan, who examines global airline travel patterns to predict the spread of diseases, said that every month, three ...
2014-10-21
VIDEO:
In this video, a Salk researcher explains how cancer evolves to become drug resistant.
Click here for more information.
LA JOLLA—Like a colony of bacteria or species of animals, cancer cells within a tumor must evolve to survive. A dose of chemotherapy may kill hundreds of thousands of cancer cells, for example, but a single cell with a unique mutation can survive and quickly generate a new batch of drug-resistant cells, making cancer hard to combat.
Now, scientists ...
2014-10-21
PENSACOLA, Fla. – Ospreys do not carry significant amounts of human pharmaceutical chemicals, despite widespread occurrence of these chemicals in water, a recent U.S. Geological Survey (USGS) and Baylor University study finds. These research findings, published by Integrated Environmental Assessment and Management is the first published study that examines the bioaccumulation of pharmaceuticals in the water-fish-osprey food web.
Pharmaceuticals have been finding their way into the environment, primarily through wastewater, urban runoff and even biosolids applied ...
2014-10-21
JACKSONVILLE, Fla. — After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.
They found that the use of trastuzumab produced a 37 percent improvement in survival and a 40 percent reduction in risk of cancer occurrence, compared to patients treated with chemotherapy alone.
These findings, published in the Journal of Clinical Oncology, demonstrate how important ...
2014-10-21
A new study, which may have implications for approaches to education, finds that brain mechanisms engaged when people allow their minds to rest and reflect on things they've learned before may boost later learning.
Scientists have already established that resting the mind, as in daydreaming, helps strengthen memories of events and retention of information. In a new twist, researchers at The University of Texas at Austin have shown that the right kind of mental rest, which strengthens and consolidates memories from recent learning tasks, helps boost future learning.
The ...
LAST 30 PRESS RELEASES:
[Press-News.org] Expert highlights research innovation and is optimistic about the future of IBS treatment
UEG Week presents new research on current therapies for irritable bowel syndrome
